Safety of Human Papillomavirus Vaccines: An Updated Review

作者: Anastasia Phillips , Cyra Patel , Alexis Pillsbury , Julia Brotherton , Kristine Macartney

DOI: 10.1007/S40264-017-0625-Z

关键词:

摘要: … Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71 countries. Unfortunately, uptake has been impacted in some countries by reduced …

参考文章(141)
S Rachel Skinner, Anne Szarewski, Barbara Romanowski, Suzanne M Garland, Eduardo Lazcano-Ponce, Jorge Salmerón, M Rowena Del Rosario-Raymundo, René H M Verheijen, Swee Chong Quek, Daniel P da Silva, Henry Kitchener, Kah Leng Fong, Céline Bouchard, Deborah M Money, Arunachalam Ilancheran, Margaret E Cruickshank, Myron J Levin, Archana Chatterjee, Jack T Stapleton, Mark Martens, Wim Quint, Marie-Pierre David, Dorothée Meric, Karin Hardt, Dominique Descamps, Brecht Geeraerts, Frank Struyf, Gary Dubin, Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study The Lancet. ,vol. 384, pp. 2213- 2227 ,(2014) , 10.1016/S0140-6736(14)60920-X
Arzu Soybilgic, Karen B Onel, Tammy Utset, Kenneth Alexander, Linda Wagner-Weiner, Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years Pediatric Rheumatology. ,vol. 11, pp. 29- 29 ,(2013) , 10.1186/1546-0096-11-29
Erna Milunka Kojic, Minhee Kang, Michelle S Cespedes, Triin Umbleja, Catherine Godfrey, Reena T Allen, Cynthia Firnhaber, Beatriz Grinsztejn, Joel M Palefsky, Jennifer Y Webster-Cyriaque, Alfred Saah, Judith A Aberg, Susan Cu-Uvin, Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women Clinical Infectious Diseases. ,vol. 59, pp. 127- 135 ,(2014) , 10.1093/CID/CIU238
Teoh Yl, Bi D, Bock Hl, Omar Sz, Omar J, Ng Ky, Gunapalaiah B, Lim Bk, Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Cervical Cancer Vaccine in Malaysian Women Aged 18-35 years: A Randomized Controlled Trial. The Medical journal of Malaysia. ,vol. 69, pp. 2- 8 ,(2014)
Serena Colafrancesco, Carlo Perricone, Lucija Tomljenovic, Yehuda Shoenfeld, Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants American Journal of Reproductive Immunology. ,vol. 70, pp. 309- 316 ,(2013) , 10.1111/AJI.12151
Andrea Schilling, Mercedes Macias Parra, Maricruz Gutierrez, Jaime Restrepo, Santiago Ucros, Teobaldo Herrera, Eli Engel, Luis Huicho, Marcia Shew, Roger Maansson, Nicole Caldwell, Alain Luxembourg, Ajoke Sobanjo Ter Meulen, Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines Pediatrics. ,vol. 136, pp. 563- 572 ,(2015) , 10.1542/PEDS.2014-4199
L. Toft, M. Storgaard, M. Muller, P. Sehr, J. Bonde, M. Tolstrup, L. Ostergaard, O. S. Sogaard, Comparison of the Immunogenicity and Reactogenicity of Cervarix and Gardasil Human Papillomavirus Vaccines in HIV-Infected Adults: A Randomized, Double-Blind Clinical Trial The Journal of Infectious Diseases. ,vol. 209, pp. 1165- 1173 ,(2014) , 10.1093/INFDIS/JIT657
Mark H Einstein, Myron J Levin, Archana Chatterjee, Nahida Chakhtoura, Peter Takacs, Grégory Catteau, Francis J Dessy, Philippe Moris, Lan Lin, Frank Struyf, Gary Dubin, Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years: Follow-up through Month 48 in a Phase III randomized study Human Vaccines & Immunotherapeutics. ,vol. 10, pp. 3455- 3465 ,(2014) , 10.4161/HV.36117
Allison L. Naleway, Brad Crane, Ning Smith, Matthew F. Daley, James Donahue, Julianne Gee, Sharon K. Greene, Theresa Harrington, Lisa A. Jackson, Nicola P. Klein, Hung Fu Tseng, Claudia Vellozzi, Eric S. Weintraub, Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011. Vaccine. ,vol. 34, pp. 167- 171 ,(2016) , 10.1016/J.VACCINE.2015.10.006